The Impact of COVID-19 on the Drug Development Ecosystem
About the Webinar
Join Cure Rare Disease for a panel discussion regarding the impact of COVID-19 on the drug development ecosystem. The panel will include supply chain, clinical, regulatory and patient advocacy perspectives. We welcome questions directed at the panelists and ask that they be submitted ahead of the webinar. If you'd like to submit questions ahead of time, please send to Kirsten ([email protected]).
Richard Horgan, MBA
Founder, Cure Rare Disease
Wendy Erler, MBA
Vice President, Patient Experience/STAR & Patient Advocacy at Alexion Pharmaceuticals, Inc.
NMO Patient Advocate
Vice President, Head of Global Supply Chain at Alexion Pharmaceuticals, Inc.
Brenda Wong, MD
Director, Duchenne Muscular Dystrophy Center, Professor, University of Massachusetts Medical School
Lauren Black, PhD
Distinguished Scientist, Charles River Labs